328 related articles for article (PubMed ID: 25513996)
41. HIV and anal cancer outcomes: a single institution's experience.
Hogg ME; Popowich DA; Wang EC; Kiel KD; Stryker SJ; Halverson AL
Dis Colon Rectum; 2009 May; 52(5):891-7. PubMed ID: 19502853
[TBL] [Abstract][Full Text] [Related]
42. Twenty-five-year experience with radical chemoradiation for anal cancer.
Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
[TBL] [Abstract][Full Text] [Related]
43. Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer.
Joseph K; Nijjar Y; Warkentin H; Schiller D; Tankel K; Usmani N; Severin D; Ghosh S; Syme A; Nijjar T; Mulder K; Doll C; Wong C; Field C
Radiother Oncol; 2015 Nov; 117(2):234-9. PubMed ID: 26306677
[TBL] [Abstract][Full Text] [Related]
44. Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer.
Lerman J; Hennequin C; Etienney I; Abramowitz L; Goujon G; Gornet JM; Guillerm S; Aparicio T; Valverde A; Cattan P; Quéro L
Eur J Cancer; 2020 Dec; 141():143-151. PubMed ID: 33137590
[TBL] [Abstract][Full Text] [Related]
45. Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.
Sparano JA; Lee JY; Palefsky J; Henry DH; Wachsman W; Rajdev L; Aboulafia D; Ratner L; Fitzgerald TJ; Kachnic L; Mitsuyasu R
J Clin Oncol; 2017 Mar; 35(7):727-733. PubMed ID: 27937092
[TBL] [Abstract][Full Text] [Related]
46. Intensity-Modulated Radiotherapy (IMRT) vs Helical Tomotherapy (HT) in Concurrent Chemoradiotherapy (CRT) for Patients with Anal Canal Carcinoma (ACC): an analysis of dose distribution and toxicities.
Yeung R; McConnell Y; Warkentin H; Graham D; Warkentin B; Joseph K; Doll CM
Radiat Oncol; 2015 Apr; 10():92. PubMed ID: 25903798
[TBL] [Abstract][Full Text] [Related]
47. Simultaneous Integrated Boost (SIB) Versus Sequential Boost in Anal Cancer Patients: A Single-Center Experience.
Khosla D; Kapoor R; Dey T; Kataria V; Singh R; Kumar D; Oinam AS; Gupta R; Rana SS; Shah J; Singh H; Irrinki S; Madan R
J Gastrointest Cancer; 2024 Jun; 55(2):759-767. PubMed ID: 38236375
[TBL] [Abstract][Full Text] [Related]
48. Anal squamous cell carcinoma in HIV/AIDS patients in the HAART era: Report of 8 cases and literature review.
Corti M; Villafañe MF; Priarone MM; Vittar N; Lewi D; Marona E; Gilardi L
Acta Gastroenterol Latinoam; 2014; 44(4):305-10. PubMed ID: 26753381
[TBL] [Abstract][Full Text] [Related]
49. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
[TBL] [Abstract][Full Text] [Related]
50. Results of age-dependent anal canal cancer treatment: a single centre retrospective study.
Claren A; Doyen J; Falk AT; Benezery K; Follana P; Frin AC; Hannoun-Lévi JM; Cavaglione G; Mari V; Gérard JP; François E
Dig Liver Dis; 2014 May; 46(5):460-4. PubMed ID: 24555918
[TBL] [Abstract][Full Text] [Related]
51. Anal cancer chemoirradiation with curative intent - a single institution experience.
Oblak I; Petric P; Anderluh F; Velenik V; Hudej R; Fras AP
Neoplasma; 2009; 56(2):150-5. PubMed ID: 19239330
[TBL] [Abstract][Full Text] [Related]
52. HIV Status and Acute Hematologic Toxicity Among Patients With Cervix Cancer Undergoing Radical Chemoradiation.
Simonds HM; Neugut AI; Jacobson JS
Int J Gynecol Cancer; 2015 Jun; 25(5):884-90. PubMed ID: 25853380
[TBL] [Abstract][Full Text] [Related]
53. Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors.
Lee AY; Golden DW; Bazan JG; Kopec M; Pelizzari CA; Aggarwal S; Chang DT; Liauw SL
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):306-312. PubMed ID: 28068238
[TBL] [Abstract][Full Text] [Related]
54. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
[TBL] [Abstract][Full Text] [Related]
56. Management of anal cancer in the HIV-positive population.
Kauh J; Koshy M; Gunthel C; Joyner MM; Landry J; Thomas CR
Oncology (Williston Park); 2005 Nov; 19(12):1634-8; discussion 1638-40, 1645 passim. PubMed ID: 16396154
[TBL] [Abstract][Full Text] [Related]
57. Clinical presentation and outcome of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience.
Martellotta F; Berretta M; Cacopardo B; Fisichella R; Schioppa O; Zanghì A; Spartà D; Cappellani A; Talamini R; Izzi I; Ridolfo A; Torresin A; Fiorica F; Tirelli U
Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1283-91. PubMed ID: 23047514
[TBL] [Abstract][Full Text] [Related]
58. Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients.
Susko M; Wang CJ; Lazar AA; Kim S; Laffan A; Feng M; Ko A; Venook AP; Atreya CE; Van Loon K; Anwar M
Oncologist; 2020 Sep; 25(9):772-779. PubMed ID: 32390297
[TBL] [Abstract][Full Text] [Related]
59. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Franco P; Mistrangelo M; Arcadipane F; Munoz F; Sciacero P; Spadi R; Migliaccio F; Angelini V; Bombaci S; Rondi N; Numico G; Ragona R; Cassoni P; Morino M; Racca P; Ricardi U
Cancer Invest; 2015 Jul; 33(6):259-66. PubMed ID: 25950188
[TBL] [Abstract][Full Text] [Related]
60. Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy.
Doyen J; Benezery K; Follana P; Ortholan C; Gérard JP; Hannoun-Levi JM; Gal J; Francois E
Dis Colon Rectum; 2013 Oct; 56(10):1125-33. PubMed ID: 24022529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
